PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $303,000 | -13.7% | 5,000 | -0.2% | 0.00% | -20.0% |
| Q1 2021 | $351,000 | +17.0% | 5,010 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $300,000 | -0.7% | 5,010 | -0.1% | 0.01% | -16.7% |
| Q3 2020 | $302,000 | +15.3% | 5,017 | +0.3% | 0.01% | +20.0% |
| Q2 2020 | $262,000 | +23.0% | 5,000 | +2.0% | 0.01% | +66.7% |
| Q2 2019 | $213,000 | -19.0% | 4,900 | -29.0% | 0.00% | -25.0% |
| Q1 2019 | $263,000 | -23.5% | 6,900 | -13.8% | 0.00% | -20.0% |
| Q4 2018 | $344,000 | -30.1% | 8,000 | -20.0% | 0.01% | -16.7% |
| Q3 2018 | $492,000 | -5.4% | 10,000 | -34.2% | 0.01% | 0.0% |
| Q3 2016 | $520,000 | -49.3% | 15,200 | -50.0% | 0.01% | 0.0% |
| Q2 2016 | $1,026,000 | +27.5% | 30,400 | +100.0% | 0.01% | -45.5% |
| Q1 2016 | $805,000 | -11.9% | 15,200 | +27.7% | 0.01% | -8.3% |
| Q4 2015 | $914,000 | +1.3% | 11,900 | -6.7% | 0.01% | +9.1% |
| Q2 2015 | $902,000 | -33.6% | 12,750 | -16.6% | 0.01% | -31.2% |
| Q1 2015 | $1,358,000 | +13.5% | 15,280 | +13.2% | 0.02% | +23.1% |
| Q4 2014 | $1,197,000 | – | 13,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |